Key result
Long-duration spaceflight is linked to a ~37% reduction in IJV cross-sectional area and incident thrombosis.
Why the study?
The serial jugular venous pulse waveform during long-duration spaceflight in microgravity had never been characterised.
Does long-duration spaceflight alter internal jugular vein cross-sectional area and pulsatile excursion in astronauts?
Observational (n=4)
No
Does long-duration spaceflight alter internal jugular vein cross-sectional area and pulsatile excursion in astronauts?
Absolute Event Rate: 0.453% vs 0.723%
p-value: p=<0.001
Long-duration spaceflight significantly alters jugular venous hemodynamics, reducing cross-sectional area and increasing pulsatile excursion, while highlighting a notable risk of internal jugular vein thrombosis.
Spaceflight-associated jugular changes may elevate thrombosis risk in astronauts; leaves open whether monitoring or countermeasures are warranted pending larger studies.
The jugular venous pulse (JVP) offers a non-invasive window into right atrial pressure. In microgravity, the serial JVP waveform during long-duration spaceflight had never been characterised. Using ECG-synchronised high-resolution ultrasound and a validated AI model, we quantified internal jugular vein cross-sectional area (IJV-CSA) throughout the cardiac cycle in four astronauts before and after flight, with in-flight measurements in one astronaut. Mean IJV-CSA fell significantly post-flight in three astronauts (ASTRO 0: from 0.723 ± 0.076 to 0.453 ± 0.061 cm 2 , ASTRO 2: − 46.0%, ASTRO 3: − 48.4%; p < 0.001). The reduction in ASTRO 0 developed between the first and fifth month in orbit. Maximum CSA declined consistently with reduced central venous pressure. Pulsatile excursion, an index never previously reported in spaceflight, increased markedly (ASTRO 0: + 105.0%, p < 0.001; ASTRO 2: + 337.1%, p < 0.001), suggesting enhanced transmission of cardiac pressure waves towards the cerebral venous compartment in the absence of hydrostatic gradients. ASTRO 1 showed the opposite pattern (minimum CSA + 42.5%, pulsatile excursion − 60.3%, p < 0.001), probably due to IJV thrombosis, representing the third documented case in space medicine. The JVP waveform retains terrestrial morphology and ECG timing in microgravity. Whether JVP parameters predict venous thrombosis or relate to glymphatic function in long-term spaceflight warrants further studies.
No takes yet. Share an insight, caveat, or question.
Zamboni et al. (2026) conducted an observational in Microgravity exposure (n=4). Long-duration spaceflight vs. Pre-flight baseline was evaluated on Mean internal jugular vein cross-sectional area (IJV-CSA) in ASTRO 0 (p=<0.001). Long-duration spaceflight significantly reduced mean internal jugular vein cross-sectional area and increased pulsatile excursion in three of four astronauts, with one astronaut developing thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: